Shares of Ajanta Pharma rose 5% to Rs 2,810 apiece on December 24 to hit five-month high after the drugmaker signed in-licensing pact with Biocon for marketing weight-loss drug Semaglutide. Under the ...
With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion. The midpoint of the projection ($61 billion) ...
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874)) has provided an update. Guangzhou Baiyunshan Pharmaceutical Holdings Company has approved the participation of its subsidiary GP Fund ...
Pharma OTT Release Date: The Malayalam film star Nivin Pauly, recognized for his roles in Premam and Hey Jude, takes the lead in Pharma, a web series that investigates the sinister aspects of the ...
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.
U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B5.00%increase; green up pointing triangle Ozempic and Wegovy—ushering in a new era of the obesity ...
Teva Pharmaceuticals Industries Limited (NYSE:TEVA) is one of the most undervalued stocks on our list. TheFly reported on December 9 that Bank of America Securities analyst Jason Gerberry reaffirmed a ...
Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the science—blockbuster obesity drugs, advances in cancer treatments, novel cell ...
Imagine walking into a travel agency in the pre-internet days. You ask for a beachfront hotel on a Greek island. Two similar options fit: One is $250 a night, the other $350. But only the pricier one ...
Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...
LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...
Isabel O’Brien is an experienced business journalist who specializes in private equity, infrastructure, and financial misconduct. Delmaine Donson / Getty Images While many Americans consider $1.5 ...